Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

Vincristine . sulfate

Microtubule inhibitor
 
BML-T117-0005 5 mg 116.00 USD
 
BML-T117-0025 25 mg 457.00 USD
Do you need bulk/larger quantities?
 
Replaces Prod. #: ALX-350-069

Plant alkaloid that arrests the cell cycle in G2/M phase by blocking mitotic spindle formation. Depolymerizes microtubules and blocks binding of tubulin to microtubule proteins. Causes aberrant tubulin polymerization. Induces apoptosis. Triggers Raf-1 activation, phosphorylation of Bcl-2 family proteins and induction of p53 expression. Cancer chemotherapeutic agent. Posttranscriptionally downregulates HIF-1α expression.

Product Specification

Alternative Name:VCR . sulfate, Leukocristine . sulfate
 
Formula:C46H56N4O10 . H2SO4
 
MW:825.0 . 98.1
 
CAS:2068-78-2
 
MI:14: 9986
 
RTECS:OH6340000
 
Purity:≥98% TLC
 
Appearance:White to off-white powder.
 
Solubility:Soluble in water (25mg/ml) or methanol.
 
Shipping:Ambient
 
Long Term Storage:-20°C
 
Use/Stability:Stable for at least 1 year after receipt when stored at -20°C. Stock solutions are stable for up to 3 months at -20°C.
 
Handling:Protect from light and moisture.
 
Technical Info/Product Notes:Note: Product is not sterile.
 
bml-t117
Please mouse over
bml-t117

Product Literature References

Co-treatment with Celecoxib or NS398 Strongly Sensitizes Resistant Cancer Cells to Antimitotic Drugs Independent of P-gp Inhibition: J.S. Lim, et al.; Anticancer Res. 36, 5063 (2016), Application(s): Cell Treatment, Abstract; Full Text
Selenate specifically sensitizes drug-resistant cancer cells by increasing apoptosis via G2 phase cell cycle arrest without P-GP inhibition: A.R. Choi, et al.; Eur. J. Pharmacol. 764, 63 (2015), Application(s): Cell Culture, Abstract;
2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF: N.J. Mabjeesh, et al.; Cancer Cell 3, 363 (2003), Abstract;
Selective toxicity of vincristine against chronic lymphocytic leukemia cells in vitro: J.A. Vilpo, et al.; Eur. J. Haematol. 65, 370 (2000), Abstract;
Vincristine-induced apoptosis in vivo in peripheral blood mononuclear cells of children with acute lymphoblastic leukaemia (ALL): E. Groninger, et al.; Br. J. Haematol. 111, 875 (2000), Abstract;
The effect of antimicrotubule agents on signal transduction pathways of apoptosis: a review: L.G. Wang, et al.; Cancer Chemother. Pharmacol. 44, 355 (1999), (Review), Abstract;
Bcl-xL is phosphorylated in malignant cells following microtubule disruption: M.S. Poruchynsky, et al.; Cancer Res. 58, 3331 (1998), Abstract;
Tubulin as a target for anticancer drugs: agents which interact with the mitotic spindle: A. Jordan, et al.; Med. Res. Rev. 18, 259 (1998), Abstract;
Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death: M.V. Blagosklonny, et al.; Cancer Res. 57, 130 (1997), Abstract;
Antimitotic natural products and their interactions with tubulin: E. Hamel; Med. Res. Rev. 16, 207 (1996), Abstract;
Bcl-2 interrupts the ceramide-mediated pathway of cell death: J. Zhang, et al.; PNAS 93, 5325 (1996), Abstract;
Interaction of vinca alkaloids with tubulin: a comparison of vinblastine, vincristine, and vinorelbine: S. Lobert, et al.; Biochemistry 35, 6806 (1996), Abstract;
Binding selectivity of rhizoxin, phomopsin A, vinblastine, and ansamitocin P-3 to fungal tubulins: differential interactions of these antimitotic agents with brain and fungal tubulins [published erratum appears in BBRC 190, 1180 (1993)]: Y. Li, et al.; BBRC 187, 722 (1992), Abstract;
Cell death induced by vincristine in the intestinal crypts of mice and in a human Burkitt's lymphoma cell line: B.V. Harmon, et al.; Cell Prolif. 25, 523 (1992), Abstract;
Interactions of the catharanthus (Vinca) alkaloids with tubulin and microtubules: R.H. Himes; Pharmacol. Ther. 51, 257 (1991), Abstract;

Related Products

Vinblastine . sulfate 

Cell cycle blocker
143-67-9, Semisynthetic from catharanthine or vindoline., ≥98% (Assay) | Print as PDF
 
ALX-350-257-M005 5 mg 64.00 USD
 
ALX-350-257-M025 25 mg 244.00 USD
Do you need bulk/larger quantities?
 

Vindoline 

2182-14-1, Isolated from Catharanthus roseus., ≥90% (assay on dried basis) | Print as PDF
 
ALX-350-102-M100 100 mg 117.00 USD
Do you need bulk/larger quantities?
 

Catharanthine . tartrate 

4168-17-6, Isolated from Catharanthus roseus., ≥90% (assay on dried basis) | Print as PDF
 
ALX-350-101-M100 100 mg 120.00 USD
 
ALX-350-101-G001 1 g 294.00 USD
Do you need bulk/larger quantities?
 

Related Literature

Brochures
Comprehensive Tools for Quantifying Cellular Responses to Oxidative Damage
Comprehensive Tools for Quantifying Cellular Responses to Oxidative Damage
Download as PDF

Brochures
Essential Research Tools for Neurodegeneration & Neural Signaling
Essential Research Tools for Neurodegeneration & Neural Signaling
Download as PDF

Product Flyers
Cell Cycle - Mitosis, CDKS & Cell Cycle Signaling
Cell Cycle - Mitosis, CDKS & Cell Cycle Signaling
Download as PDF

Technical Posters
Disease-Associated Stress Signaling
Disease-Associated Stress Signaling
Download as PDF

All new literature pieces

Recommend this page

 
For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2017 Enzo Life Sciences, Inc.,